Randomized phase II trial of anthracycline-free and anthracycline-containing neoadjuvant carboplatin chemotherapy regimens in stage I-III triple-negative breast cancer (NeoSTOP)

PURPOSE: Addition of carboplatin (Cb) to anthracycline chemotherapy improves pathologic complete response(pCR), and carboplatin plus taxane regimens also yield encouraging pCR rates in TNBC. Aim of the NeoSTOP multisite randomized phase II trial was to assess efficacy of anthracycline-free and anthr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Sharma, Priyanka, Kimler, Bruce F., O’Dea, Anne, Nye, Lauren, Wang, Yen Y., Yoder, Rachel, Staley, Joshua M., Prochaska, Lindsey, Wagner, Jamie, Amin, Amanda L., Larson, Kelsey, Balanoff, Christa, Elia, Manana, Crane, Gregory, Madhusudhana, Sheshadri, Hoffmann, Marc, Sheehan, Maureen, Rodriguez, Roberto, Finke, Karissa, Shah, Rajvi, Satelli, Deepti, Shrestha, Anuj, Beck, Larry, McKittrick, Richard, Pluenneke, Robert, Raja, Vinay, Beeki, Venkatadri, Corum, Larry, Heldstab, Jaimie, LaFaver, Stephanie, Prager, Micki, Phadnis, Milind, Mudaranthakam, Dinesh Pal, Jensen, Roy A., Godwin, Andrew K., Salgado, Roberto, Mehta, Kathan, Khan, Qamar
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7887017/
https://ncbi.nlm.nih.gov/pubmed/33208340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-3646
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados